Piezolabs is developing innovative vascular devices designed to manage blood flow and improve treatment outcomes. Tailored to either prevent or promote clot formation based on patient needs, these devices have the potential to reduce or eliminate the need for dual antiplatelet therapy (DAPT) after procedures, lowering the risks of bleeding and clotting. The company is focused on advancing vascular care with its cutting-edge technology.